Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire.

@article{Seyler2003MediumtermSM,
  title={Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, C{\^o}te d'Ivoire.},
  author={Catherine Seyler and Xavier Anglaret and Nicole Dakoury-Dogbo and Eug{\`e}ne Messou and Siaka Tour{\'e} and Christine Danel and Nafissa Diakit{\'e} and Alain Daudi{\'e} and Andr{\'e} Inwoley and Chantal E Maurice and Besigin Tonwe-Gold and François Rouet and Th{\'e}r{\`e}se N'dri-Yoman and Roger Salamon},
  journal={Antiviral therapy},
  year={2003},
  volume={8 5},
  pages={385-93}
}
OBJECTIVES To evaluate survival, morbidity, and CD4 and viral load (VL) evolution in HIV-infected adults receiving antiretroviral therapy (ART) in Côte d'Ivoire. METHODS Since 1996, 723 HIV-infected adults have been followed up in the ANRS 1203 cohort study in Abidjan. For those patients who received ART, we describe data between ART initiation and August 2002. RESULTS One-hundred-and-one adults (61% women) were followed up under ART for a median of 17 months. At ART initiation, median age… CONTINUE READING